E-ISSN 2231-3206 | ISSN 2320-4672
 

Original Research

Online Publishing Date:
08 / 01 / 2013

 


Oxidative stress in epilepsy with comorbid psychiatric illness

Manmohan Krishna Pandey, Purnima Mittra, Pradeep Kumar Maheshwari.


Abstract
Background: Free radicals have been implicated in the development of various acute and chronic diseases of brain. The present cross sectional study was designed to illustrate the oxidative stress in epilepsy with co morbid psychiatric illness using malondialdehyde as only few studies were available in this context.

Objective: To evaluate the malondialdehyde (MDA) as a marker of oxidative stress in epilepsy with psychiatric co morbidity.

Materials and Methods: The present cross sectional study had 210 samples which were divided in 5 groups including age and sex matched control. The MDA formation was estimated using the level of thiobarbituric acid reactive substances (TBARS) using spectrophotometry. The statistical analysis was done by using SPSS software and results were described with unpaired T test and p value.

Results: MDA levels were significantly higher in epilepsy with psychiatric co morbidity, psychosis and depression than control. On further comparison, the MDA levels were higher in persons of epilepsy with psychiatric co morbidity than with psychosis or depression.

Conclusion: Level of oxidative stress was significantly higher in epilepsy with co morbid psychiatric illness as compared to control.

Key words: Epilepsy, Psychosis, Depression, Malondialdehyde(MDA), Lipid Peroxidation Product (LPP)


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Manmohan Krishna Pandey
Articles by Purnima Mittra
Articles by Pradeep Kumar Maheshwari
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Manmohan Krishna Pandey, Purnima Mittra, Pradeep Kumar Maheshwari. Oxidative stress in epilepsy with comorbid psychiatric illness. Natl J Physiol Pharm Pharmacol. 2013; 3(1): 92-96. doi:10.5455/njppp.2013.3.92-96


Web Style

Manmohan Krishna Pandey, Purnima Mittra, Pradeep Kumar Maheshwari. Oxidative stress in epilepsy with comorbid psychiatric illness. https://www.njppp.com/?mno=28365 [Access: March 14, 2024]. doi:10.5455/njppp.2013.3.92-96


AMA (American Medical Association) Style

Manmohan Krishna Pandey, Purnima Mittra, Pradeep Kumar Maheshwari. Oxidative stress in epilepsy with comorbid psychiatric illness. Natl J Physiol Pharm Pharmacol. 2013; 3(1): 92-96. doi:10.5455/njppp.2013.3.92-96



Vancouver/ICMJE Style

Manmohan Krishna Pandey, Purnima Mittra, Pradeep Kumar Maheshwari. Oxidative stress in epilepsy with comorbid psychiatric illness. Natl J Physiol Pharm Pharmacol. (2013), [cited March 14, 2024]; 3(1): 92-96. doi:10.5455/njppp.2013.3.92-96



Harvard Style

Manmohan Krishna Pandey, Purnima Mittra, Pradeep Kumar Maheshwari (2013) Oxidative stress in epilepsy with comorbid psychiatric illness. Natl J Physiol Pharm Pharmacol, 3 (1), 92-96. doi:10.5455/njppp.2013.3.92-96



Turabian Style

Manmohan Krishna Pandey, Purnima Mittra, Pradeep Kumar Maheshwari. 2013. Oxidative stress in epilepsy with comorbid psychiatric illness. National Journal of Physiology, Pharmacy and Pharmacology, 3 (1), 92-96. doi:10.5455/njppp.2013.3.92-96



Chicago Style

Manmohan Krishna Pandey, Purnima Mittra, Pradeep Kumar Maheshwari. "Oxidative stress in epilepsy with comorbid psychiatric illness." National Journal of Physiology, Pharmacy and Pharmacology 3 (2013), 92-96. doi:10.5455/njppp.2013.3.92-96



MLA (The Modern Language Association) Style

Manmohan Krishna Pandey, Purnima Mittra, Pradeep Kumar Maheshwari. "Oxidative stress in epilepsy with comorbid psychiatric illness." National Journal of Physiology, Pharmacy and Pharmacology 3.1 (2013), 92-96. Print. doi:10.5455/njppp.2013.3.92-96



APA (American Psychological Association) Style

Manmohan Krishna Pandey, Purnima Mittra, Pradeep Kumar Maheshwari (2013) Oxidative stress in epilepsy with comorbid psychiatric illness. National Journal of Physiology, Pharmacy and Pharmacology, 3 (1), 92-96. doi:10.5455/njppp.2013.3.92-96